Many patients undergoing heart surgery such as coronary artery bypass grafting (CAGB) may have been given Trasylol to decrease bleeding. The FDA reports that Trasylol "has been linked in two scientific publications to higher risks of serious side effects including kidney problems, heart attacks and strokes in patients who undergo artery bypass graft surgery."
If you have taken Trasylol® and have had a heart attack, stroke or kidney failure, learn more about your options and get an instant answer to your questions. Call today and speak with an Attorney: 1.800.838.0800.